This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 1994-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-2005
Title: John Frenz: Innovator in DNase Research
Introduction
John Frenz is a notable inventor based in Millbrae, CA (US), recognized for his contributions to the field of biotechnology. With a total of 4 patents to his name, he has made significant strides in the development of pharmaceutical applications.
Latest Patents
Frenz's latest patents focus on the purified forms of DNase. His inventions provide the identification and characterization of two components of a recombinant preparation of DNase. These components include the purified deamidated and non-deamidated human DNases. The patents detail the separation of these components and the use of the non-deamidated species as a pharmaceutical per se. In particular, these compositions are disclosed within a plastic vial for use in administering to patients suffering from pulmonary distress.
Career Highlights
John Frenz is currently associated with Genentech, Inc., a leading biotechnology company. His work has contributed to advancements in therapeutic solutions for respiratory conditions, showcasing his commitment to improving patient care through innovative research.
Collaborations
Frenz has collaborated with esteemed colleagues such as Mary B Sliwkowski and Steven J Shire, further enhancing the impact of his research in the field.
Conclusion
John Frenz's innovative work in DNase research exemplifies the importance of biotechnology in addressing health challenges. His contributions continue to influence the development of effective treatments for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile